首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1477328

细胞治疗市场，依治疗类型、按适应症、依最终用户、地理位置

Cell Therapy Market, By Therapy Type, By Indication, By End User, By Geography

出版日期: 2024年04月16日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球细胞治疗市值为25.838亿美元，预计2031年将达到48.475亿美元，2024年至2031年的年复合成长率（CAGR）为9.4%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	25.838 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	9.40%	2031 年价值预测：	48.475 亿美元

图 1. 细胞治疗市场占有率 (%)，按地区划分，2024 年

由于慢性病盛行率上升以及全球老年人口不断增加，预计全球细胞治疗市场将在未来十年大幅成长。细胞疗法是一个新兴且有前景的领域，利用活细胞修復、替换或再生受损的组织和细胞。细胞培养技术、相关技术和监管批准的进步支持了治疗血液疾病、癌症、自体免疫疾病和其他疾病的新疗法的开发。随着研发方面的大量投资和不断增加的监管批准，细胞治疗行业有望在不久的将来改变医疗保健产业。

市场动态：

全球细胞治疗市场的成长是由癌症和其他慢性疾病盛行率上升、细胞研究资金增加以及开发新疗法的技术进步等因素所推动的。此外，全球易患疾病的老年人口不断增加，预计将增加需求。然而，与细胞疗法开发相关的高成本和对新疗法的严格监管限制了市场成长。由于中国、印度和巴西等国家医疗保健投资不断增长，新兴经济体为市场参与者提供了利润丰厚的机会。预计对干细胞的持续研究和细胞疗法的新应用将在预测期内创造新的途径。

研究的主要特点：

该报告对全球细胞治疗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（百万美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球细胞治疗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球细胞治疗市场迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球细胞治疗市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 9 章：竞争格局

公司简介
- Bristol Myers Squibb Company
- Amgen Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Allogene Therapeutics
- Athersys, Inc.
- Orchard Therapeutics
- JW Therapeutics Co., Ltd.
- Dendreon Pharmaceuticals LLC.
- Autolus Therapeutics
- APAC Biotech
- CORESTEM, Inc.
- BioCardia, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Oxford Biomedica
- CASI Pharmaceuticals Inc.

第 10 章：分析师建议

命运之轮
分析师观点
连贯的机会图

第 11 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI5413

Global cell therapy market is estimated to be valued at USD 2,583.8 Mn in 2024 and is expected to reach USD 4,847.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 2,583.8 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.40%	2031 Value Projection:	US$ 4,847.5 Mn

Figure 1.Cell Therapy Market Share (%), By Region, 2024

Global cell therapy market is expected to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging and promising field that works with living cells to repair, replace or regenerate damaged tissues and cells. Advancements in cell culture techniques, associated technologies and regulatory approvals have supported the development of new therapies to treat blood disorders, cancers, autoimmune diseases and others. With significant investments in research and development and growing regulatory approvals, the cell therapy industry is poised to transform healthcare in the near future.

Market Dynamics:

Global cell therapy market growth is driven by factors such as rising prevalence of cancer and other chronic diseases, increase in funds for cell-based research, and advancement of technologies to develop novel therapies. Moreover, growing geriatric population worldwide prone to diseases is expected to boost demand. However, high costs associated with cell therapy development and stringent regulations for new therapies limits the market growth. Emerging economies offer lucrative opportunities for market players due to growing healthcare investments in countries like China, India and Brazil. Continuous research on stem cells and new applications of cell therapy are anticipated to create new avenues over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global cell therapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Bristol Myers Squibb Company, Amgen Inc., Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Allogene Therapeutics, Athersys, Inc., Orchard Therapeutics, JW Therapeutics Co., Ltd., Dendreon Pharmaceuticals LLC., Autolus Therapeutics, APAC Biotech, CORESTEM, Inc., BioCardia, Inc., JCR Pharmaceuticals Co., Ltd., Oxford Biomedica, and CASI Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy market.

Detailed Segmentation-

By Therapy Type:
- Stem Cells
- T-cells
- Dendritic Cells
- NK-cells
By Indication:
- Oncology
- Cardiology
- Neurology
- Others
By End User:
- Hospitals
- Clinics
- Research Institutes
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bristol Myers Squibb Company
- Amgen Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Allogene Therapeutics
- Athersys, Inc.
- Orchard Therapeutics
- JW Therapeutics Co., Ltd.
- Dendreon Pharmaceuticals LLC.
- Autolus Therapeutics
- APAC Biotech
- CORESTEM, Inc.
- BioCardia, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Oxford Biomedica
- CASI Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Technological Advancements
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Fundings and Investments
PEST Analysis
Porter's Analysis

4. Global Cell Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Cell Therapy Market, By Therapy Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
T-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Dendritic Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
NK-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Cell Therapy Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Cell Therapy Market, By End User, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Cell Therapy Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Bristol Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Amgen Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Allogene Therapeutics
- Athersys, Inc.
- Orchard Therapeutics
- JW Therapeutics Co., Ltd.
- Dendreon Pharmaceuticals LLC.
- Autolus Therapeutics
- APAC Biotech
- CORESTEM, Inc.
- BioCardia, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Oxford Biomedica
- CASI Pharmaceuticals Inc.